ABVC BioPharma, Inc. Increase (Decrease) in Accounts Payable, Trade
ABVC BioPharma, Inc. (ABVC) reported Increase (Decrease) in Accounts Payable, Trade of -$6.55 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2021-11-15
- ABVC BioPharma, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2021-09-30 was $11.45K, a 24.98% decline year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2021-06-30 was -$5.29K.
- ABVC BioPharma, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2021-03-31 was -$12.71K.
- ABVC BioPharma, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2020-12-31 was -$30.00, a 100.06% decline year-over-year.
- ABVC BioPharma, Inc. increase (decrease) in accounts payable, trade for fiscal 2020 was -$951.00, a 101.89% decline from fiscal 2019.
- ABVC BioPharma, Inc. increase (decrease) in accounts payable, trade for fiscal 2019 was $50.24K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2021-09-30 | $11.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $6.16K derived: sum of 2 quarters · filed 2021-11-15 | -$6.55K 10-Q · filed 2021-11-15 | -$6.58K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | -$5.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$18.00K 10-Q · filed 2021-08-12 | -$18.03K derived: sum of 3 quarters · filed 2021-08-12 | -$2.77K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-03-31 | -$12.71K 10-Q · filed 2021-05-10 | -$12.74K derived: sum of 2 quarters · filed 2021-05-10 | $2.52K derived: sum of 3 quarters · filed 2021-11-15 | -$10.03K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-12-31 | -$30.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $15.23K derived: sum of 2 quarters · filed 2021-11-15 | $2.68K derived: sum of 3 quarters · filed 2021-11-15 | -$951.00 10-K · filed 2021-03-16 |
| 2020-09-30 | $15.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.71K derived: sum of 2 quarters · filed 2021-11-15 | -$921.00 10-Q · filed 2021-11-15 | $46.48K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$12.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$16.18K 10-Q · filed 2021-08-12 | $31.22K derived: sum of 3 quarters · filed 2021-08-12 | $24.90K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$3.63K 10-Q · filed 2021-05-10 | $43.77K derived: sum of 2 quarters · filed 2021-05-10 | $37.45K derived: sum of 3 quarters · filed 2021-05-10 | |
| 2019-12-31 | $47.41K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $41.09K derived: sum of 2 quarters · filed 2021-03-16 | $50.24K 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$6.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | $2.84K 10-Q · filed 2020-11-17 | ||
| 2019-06-30 | $9.16K 10-Q · filed 2020-08-14 |